The NoHoW protocol: a multicentre 2×2 factorial randomised controlled trial investigating an evidence-based digital toolkit for weight loss maintenance in European adults. Issue 9 (30th September 2019)

• Record Type: Journal Article
• Authors: Scott, Sarah Ellen; Duarte, Cristiana; Encantado, Jorge; Evans, Elizabeth H; Harjumaa, Marja; Heitmann, Berit Lilienthal; Horgan, Graham W; Larsen, Sofus C; Marques, Marta Moreira; Mattila, Elina; Matos, Marcela; Mikkelsen, Marie-Louise; Palmeira, António L; Pearson, Beth; Ramsey, Lauren; Sainsbury, Kirby; Santos, Inês; Sniehotta, Falko; Stalker, Carol; Teixeira, PJ; Stubbs, R. James
• Is Part Of: BMJ open. Volume 9:Issue 9(2019)
• Publication Date: 2019-09-30
• Subjects: Weight loss maintenance -- Digital health -- Behaviour change -- Self-regulation -- Emotion regulation -- Motivation; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2019-029425
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Obesity and associated diseases place a severe burden on healthcare systems. Behavioural interventions for weight loss (WL) are successful in the short term but often result in weight regain over time. Self-regulation of eating and activity behaviours may significantly enhance weight loss maintenance (WLM) and may be effectively augmented by contextual behavioural approaches to emotion regulation. The NoHoW trial tests the efficacy of a theoretically informed, evidence-based digital toolkit using a mobile-enabled website, activity trackers and Wi-Fi scales for WLM aiming to target (1) self-regulation and motivation, and (2) emotion regulation in adults who achieved clinically significant (≥5%) WL in the previous 12 months (initial body mass index (BMI) ≥25 kg/m 2 ). Methods and analysis: The study is an 18-month, 3-centre, 2×2 factorial single-blind, randomised controlled trial, which recruited 1627 participants achieving ≥5% WL between March 2017 and March 2018. Participants are randomly allocated to one of four arms: (1) self-monitoring only (self-weighing and activity tracker), (2) self-regulation and motivation, (3) emotion regulation or (4) combined self-regulation, motivation and emotion regulation. Participants attend four clinical investigation days at 0, 6, 12 and 18 months and are instructed to use the digital toolkit for 18 weeks during the first 6 months and at their discretion for the remaining 12 months. The primary outcome is change in weight (kg) at 12 months from baseline. Secondary outcomes are body composition (eg, bioimpedance analysis), health biomarkers (glycated haemoglobin, lipids, blood pressure, hair cortisol), dietary intake, physical activity, sleep, motivational, self-regulatory, emotion regulatory moderators/mediators of WLM, engagement, user experience, acceptability and cost-effectiveness of the interventions. Ethics and dissemination: Ethical approval was granted by Institutional Ethics Committees at the Universities of Leeds (17–0082; 27 February 2017), Lisbon (17/2016; 20 February 2017) and Capital Region of Denmark (H-16030495, 8 March 2017). Results will be published in scientific journals. Trial registration number: ISRCTN88405328 .